Answer: yes it does in patients with advance liver disease from viral hepatitis.
Explanation:
Evidence has shown association between hepatitis C and low bone mineral density and fracture. For long it has been known that patients with advanced liver disease from viral hepatitis and other causes have lower bone mineral density (BMD) and higher risk for fracture, noting that hepatic osteopathy is more likely in individuals with advanced liver disease or who are transplantation candidates. “The main question is whether or not the increased risk for osteoporosis and fracture is due to something intrinsically related to chronic HCV infection or due to risk factors associated with HCV.”
Pharmacodynamics is the branch of pharmacology concerned with the effects of drugs and the mechanism of their action. So the closest answer to this question is Pharmacodynamics